Ergocalciferol and Opdivo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Opdivo (nivolumab). Common drug interactions include liver disorder among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Opdivo. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Ergocalciferol?

Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.

What is Opdivo?

Opdivo has active ingredients of nivolumab. eHealthMe is studying from 56,331 Opdivo users. Check the latest studies of Opdivo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

69 people who take Ergocalciferol and Opdivo together, and have interactions are studied.

Ergocalciferol and Opdivo drug interactions.

What are the common drug interactions of Ergocalciferol and Opdivo, by gender? *:

female:

Liver disorder (liver diseases)
Malignant melanoma (skin cancer rises from melancytes)
Malignant neoplasm progression (cancer tumour came back)
Metastases to liver (cancer spreads to liver)
Renal failure (kidney dysfunction)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Death
Fatigue (feeling of tiredness)
Drug ineffective
Haemoglobin decreased

male:

Fatigue (feeling of tiredness)
Decreased appetite
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Nausea (feeling of having an urge to vomit)
Skin exfoliation (removal of the oldest dead skin cells)
Tumour pain
Malaise (a feeling of general discomfort or uneasiness)
Abdominal mass (localized enlargement or swelling in the human abdomen)
Anal fissure
Dizziness

What are the common drug interactions of Ergocalciferol and Opdivo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Malignant neoplasm progression (cancer tumour came back)

40-49:

Nausea (feeling of having an urge to vomit)
Skin exfoliation (removal of the oldest dead skin cells)
Stomatitis (inflammation of mucous membrane of mouth)
Adverse event
Blood pressure increased
Decreased appetite
Diarrhoea
Dizziness
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

50-59:

Drug ineffective
Pancreatitis (inflammation of pancreas)
Brain neoplasm (tumour of brain)
Colon cancer metastatic (cancer of colon spreads to other part of body)
Constipation
Eyelid ptosis (falling of the upper or lower eyelid)
Malignant neoplasm progression (cancer tumour came back)
Neuroendocrine carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems)

60+:

Fatigue (feeling of tiredness)
Death
Malaise (a feeling of general discomfort or uneasiness)
Pain in extremity
Abdominal mass (localized enlargement or swelling in the human abdomen)
Anal fissure
Dry mouth
Hair colour changes
Impaired healing
Limb discomfort (discomfort in leg)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 31 people, 44.93%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 4 people, 5.80%
Malignant Melanoma (skin cancer rises from melancytes): 4 people, 5.80%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Ergocalciferol and Opdivo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously